AbbVie Inc.

AbbVie Inc. is a prominent biopharmaceutical company known for its innovative approach to addressing complex health challenges. Its primary function revolves around the discovery, development, manufacturing, and sale of pharmaceutical products worldwide. AbbVie has made significant contributions to the medical field through its portfolio that encompasses therapies across various sectors, most notably in immunology, oncology, neuroscience, and virology. The company is well-known for its flagship drug, Humira, which is widely used in treating several autoimmune conditions, reaffirming its leadership in immunology. Headquartered in North Chicago, Illinois, AbbVie was established in 2013 as a spin-off from Abbott Laboratories, enabling it to solely focus on advanced biopharmaceutical developments. The company's robust pipeline, continuous investment in research and development, and strategic collaborations highlight its commitment to pioneering medical advances. In the financial markets, AbbVie is recognized as a significant player in the healthcare sector, impacting global health outcomes and contributing to medical advancements. Its role is vital in providing solutions for some of the most debilitating diseases, supporting its standing as a key player in biopharmaceutical innovation.